IARC TECHNICAL PUBLICATIONS - WHO

2y ago
100 Views
3 Downloads
4.69 MB
49 Pages
Last View : 5m ago
Last Download : 3m ago
Upload by : Helen France
Transcription

IARC TECHNICAPUBLICATIONSPLANNING AND DEVELOPINGPOPULATION-BASED CANCERREGISTRATION IN LOW- ANDMIDDLE-INCOME SETTINGSFREDDIE BRAY, ARIANA ZNAOR, PATRICIA CUEVA,ANNE KORIR, RAJARAMAN SWAMINATHAN, ANDREAS ULLRICH,SUSAN A. WANG, AND DONALD MAXWELL PARKINIARC TECHNICALPUBLICATION NO. 43

IARC TECHNICAPUBLICATIONSPLANNING AND DEVELOPINGPOPULATION-BASED CANCERREGISTRATION IN LOW- ANDMIDDLE-INCOME SETTINGSFREDDIE BRAY, ARIANA ZNAOR, PATRICIA CUEVA,ANNE KORIR, RAJARAMAN SWAMINATHAN, ANDREAS ULLRICH,SUSAN A. WANG, AND DONALD MAXWELL PARKINIARC TECHNICALPUBLICATION NO. 43

Published by the International Agency for Research on Cancer,150 cours Albert Thomas, 69372 Lyon Cedex 08, France International Agency for Research on Cancer, 2014Distributed byWHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland(tel: 41 22 791 3264; fax: 41 22 791 4857; email: bookorders@who.int).Publications of the World Health Organization enjoy copyright protection in accordance with the provisions ofProtocol 2 of the Universal Copyright Convention. All rights reserved.The designations employed and the presentation of the material in this publication do not imply the expression ofany opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal statusof any country, territory, city, or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed orrecommended by the World Health Organization in preference to others of a similar nature that are not mentioned.Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.The authors alone are responsible for the views expressed in this publication.The International Agency for Research on Cancer welcomes requests for permission to reproduce or translate itspublications, in part or in full. Requests for permission to reproduce or translate IARC publications – whether for sale orfor non-commercial distribution – should be addressed to the IARC Communications Group, at: publications@iarc.fr.Cover image: Photo taken by Max Parkin at the Nairobi Hospital, Kenya, in June 2010. The photo shows the MedicalRecords Department of the hospital and the supervisor, Mr Desmond Ogwang (left, seated at computer).This book is available in electronic format /treport-pub/treport-pub43/index.php.IARC Library Cataloguing in Publication DataPlanning and developing population-based cancer registration in low- and middle-income settings / Freddie Bray,Ariana Znaor, Patricia Cueva [et al.](IARC Technical Publications; 43)1. Registries – standards 2. Neoplasms – epidemiology 3. Neoplasms – prevention & control 4. Data Collection –methods 4. Quality Indicators, Health Care 5. Developing CountriesI. Bray, Freddie II. SeriesISBN 978-92-832-0436-7ISSN 1012-7348(NLM Classification: W1)

Table of contentsContributors. vAcknowledgements. viForeword. viiPreface. viiiExecutive summary. ixAbbreviations. xChapter 1. 1IntroductionChapter 2. 3The role and status of population-based cancer registrationChapter 3. 9Planning and developing a population-based cancer registryChapter 4. 15Sources of information for the population-based cancer registryChapter 5. 21Quality control at the population-based cancer registryChapter 6. 27Making the population-based cancer registry heard – reporting the resultsReferences. 31Annex 1. 32CanReg5Annex 2 . 33Selected data quality indicators by country or region

ContributorsAuthorsDr Freddie BraySection of Cancer InformationInternational Agency for Researchon Cancer (IARC)150 cours Albert Thomas69372 Lyon Cedex 08FranceDr Patricia CuevaSociedad de Lucha Contra elCáncerSOLCA, Núcleo de QuitoAv. Eloy Alfaro 53-94 y Los PinosCasilla 1711 4965 CCIQuitoEcuadorDr Anne KorirNairobi Cancer RegistryKenya Medical Research InstituteCentre for Clinical ResearchP.O. Box 20778, 00202NairobiKenyaDr Donald Maxwell ParkinThe African Cancer RegistryNetwork (AFCRN)Prama House267 Banbury Road, OxfordOX2 7HTUnited KingdomDr Susan A. WangDepartment of Immunization,Vaccines and BiologicalsWorld Health Organization20 Avenue Appia1211 Geneva 27SwitzerlandDr Rajaraman SwaminathanHead, Department of Biostatisticsand Cancer RegistryCancer Institute (WIA)38 Sardar Patel RoadChennai 600036IndiaDr Ariana ZnaorSection of Cancer InformationInternational Agency for Researchon Cancer (IARC)150 cours Albert Thomas69372 Lyon Cedex 08FranceDr Andreas UllrichFocal point cancercontrol/Liaison IARCManagement of NoncommunicableDiseases DepartmentWorld Health Organization20 Avenue Appia1211 Geneva 27SwitzerlandProduction TeamKaren MüllerEnglish EditorSylvia LesagePublishing AssistantContributorsv

AcknowledgementsThe authors would like to express their gratitude to Professor David Roder, Cancer Epidemiology and PopulationHealth, School of Population Health, University of South Australia and Senior Principal Research Scientist, SouthAustralian Health and Medical Research Institute, and to Professor Rajesh Dikshit, Tata Memorial Hospital and thePrincipal Investigator of the IARC Regional Hub for Cancer Registration, Mumbai, for their insightful comments andsuggestions on an earlier draft of this document.IARC and WHO thank the GAVI Alliance, whose unrestricted financial support has made the production of thisdocument possible.viAcknowledgements

ForewordCancer control planning withoutreliable data from cancer registriesis prone to misplaced emphasis andwasted investment. This is exactlythe position many countries stillfind themselves in at the beginningof the 21st century. Particularly inlow- and middle-income countries,this situation reflects a lack of advocacy for the value of registries,a lack of trained staff and other resources, and a lack of prioritizationfor “counting cancers” in among themany demands on limited healthcare services.Nevertheless, there are positive signs that the position may bechanging. First, the emphasis onnoncommunicable diseases (NCDs)at the highest political level andrecognition of their role in hampering human development are changing priorities within countries andamong donors. Second, the WorldHealth Organization Member Statesagreed that among the indicators of progress in the fight againstNCDs is the need to record “cancerincidence, by type of cancer, per100 000 population”, thus placing anonus on countries to establish population-based cancer registries andto report on progress. At the sametime, several technical and funding organizations are working in acooperative and coordinated manner to improve the quality and cov-erage of cancer registration underthe auspices of the Global Initiativefor Cancer Registry Development(GICR). This is leading to noticeableimprovements in training, advocacy,and data collection and analysis.This dual approach – top-down andbottom-up – will translate into a stepchange in the availability of reliabledata on cancer occurrence globally.This, in turn, would be a cornerstoneof cancer control in the comingdecades.Accepting the value of cancerregistration, what should be measured? Certainly in addition to incidence, there is enormous value inestimating cancer survival by following up cancer patients with respectto their vital status so as to obtaininformation on the quality of cancerservices at the population level. Ascancer information systems develop, there are further opportunitiesto link cancer registry databaseswith other data sets on, for example, cancer screening, treatment,co-morbidities, and so on. Registrydata can also catalyse research intocauses of the disease and the effectiveness of national or regionalintervention strategies.Knowing what to measure isfundamental, but how should itbe done? This is where the current publication fulfils an importantfunction, providing practical guidance on gathering, processing, andchecking the quality of informationcollected, within the context of apopulation-based cancer registrysituated within a low- or middleincome country.As Director of the InternationalAgency for Research on Cancer,this book has particular resonancefor me. Upon its inception 50 yearsago, the Agency had a prime goalof studying the geographical variations in cancer occurrence to learnabout the causes and prevention ofthe disease. This led to five decadesof work alongside an uncountablenumber of impressively dedicatedcolleagues, determined to developcancer registries under the mostdemanding of circumstances; theirshas frequently been a labour of love.It is my firm conviction that the contents of this book, developed withinan enduring partnership with theInternational Association of CancerRegistries, represent another important step in supporting cancer registrars as they seek to provide thefigures needed to ensure that thebest possible cancer control measures are available for all populations worldwide.Dr Christopher P. WildDirector, International Agencyfor Research on CancerForewordvii

PrefacePopulation-based cancer registries have provided decisive contributions to cancer epidemiology andcancer control, spanning three quarters of a century. Cancer registrationbegan in earnest in the 1930s and1940s, at the same time that modern epidemiology began to seek thecauses of chronic diseases. Cancerregistration progressively expandedduring the subsequent decades, andcancer registries have now becomedefinitive and unique resources formeasuring the cancer burden in thecommunity (still today, no comparable data system is available forother major diseases). Registrieshave contributed in a number of important ways across the spectrum ofcancer control, from determining theburden and geographical variationin cancer, and thereby aiding understanding of its causes, through topopulation-based survival analysesand assessments of the quality ofdiagnosis and care received by cancer patients.The accumulation and expansion of registry data have enabledgeographical and time trends ofincidence, mortality, survival, andprevalence to flourish. The individual data sets collected havealso fed into a very large numberof analytical epidemiological stud-viiiPrefaceies. More recent developments include research based on registrylinkages with clinical databanksand biological sample repositories.Although these achievements arebecoming standard practice in registries in industrialized countries,much work still remains to ensurea similar development in low- andmiddle-income countries (LMICs).Registry coverage with high-qualitydata remains well below 10% in Africa, Asia, and Latin America, andthere is an urgent need to supportthe initiation, expansion, and development of registries in many LMICs.The approach relies upon the synergy between local resources andwillingness on the one hand, and international cooperation on the other.It is in this context that the International Association of Cancer Registries, an organization with memberregistries across all continents, willbe pleased to link activities and future plans with the ongoing development of the IARC Regional Hubs forCancer Registration, as part of theGlobal Initiative for Cancer RegistryDevelopment (GICR).A key requirement for the development of population-based cancerregistries is resources to supportthe delivery of training. Needs vary,from detailed how-to guides for cancer registrars to instruction in statistical methodologies for the analysisof registry data sets. This guidancedocument provides an overview ofthe key concepts in cancer registration, covering the steps involved inplanning a registry, the sources ofinformation a registry will need toaccess, methods for ensuring dataquality, and how registry resultsshould be reported. As such, it willbe of value to those who are seekingto establish a registry or are in theearly stages of developing a registry. It covers the major componentsthat need to be thought about whensetting up a registry and ensuringthat it provides the necessary information for its main stakeholders –especially those involved in cancercontrol planning.Roberto Zanetti, MD, PhDPresident, InternationalAssociation of Cancer RegistriesDavid Forman, PhDHead, Section of CancerInformation, InternationalAgency for Research on CancerExecutive Secretary,International Associationof Cancer Registries

Executive summaryMore than 20 million new casesof cancer are predicted worldwide in2025, with four fifths of the burdenfalling on low- and middle-incomecountries (LMICs). To understandthe local cancer situation and tacklethe increasing incidence, there is apressing need for planners to haverelevant and unbiased data on thecancer burden in their communities.Population-based cancer registries(PBCRs) provide such informationand are a standard requirement forcancer control planning and evaluation in every country of the world.They are especially valuable inLMICs, where few other populationbased data on cancer occurrenceand outcome are available.In planning a PBCR, there aremany elements to consider, including the definition of the population,the personnel required, the physicallocation of the registry, the necessary equipment and office space,adequate financing, ensuring thatlegal aspects and confidentiality areappropriately addressed, and – lastbut not least – the appointment ofan advisory committee to overseethe activities of the registry. Most ofthe requirements for planning andmonitoring can be achieved throughregistration of a subset (sample) ofthe national population, using oneregional PBCR or a series of regional PBCRs. The political will and support of the key stakeholders are veryimportant at the outset to ensure thesustainability of the PBCR. Successalso depends on the collaboration ofclinicians, pathologists, and staff inadministration in ensuring access totheir data.PBCRs rely on the use of multiple sources of information on cancer cases in the target population.These sources can be grouped intothree broad categories: hospitals,laboratories, and death certificates.Registry procedures allow identification of the same cancer case fromdifferent sources (while avoiding duplicate registrations). The minimumdata set is the list of variables for agiven case that is essential for anycancer registry to collect. Several ofthe variables require coding, to facilitate analysis. Standard, international coding schemes are availablefor some variables, and cancer registries should use them so that comparison of results between registriesis possible. The most important arethe coding of the tumour (site, histology, behaviour, basis of diagnosis),using the International Classificationof Diseases for Oncology (ICD-O),and the coding of stage, using thetumour–node–metastasis (TNM)staging system.As well as collating the data,PBCRs are responsible for analysing and reporting. Cancer incidencereports contain information on all reportable cancers and represent themain deliverable of a cancer registry, providing feedback to the stakeholders and the data providers. Themain components of the report arebackground information, evaluation and presentation of the results,and the tabular section. All PBCRsshould be able to provide some objective indication of the quality of thereported data. The methods available are described in the contextof lower-income settings and coverthe four dimensions of data quality:comparability, validity, timeliness,and completeness.To support the local planningand development of PBCRs in countries within defined regions, a seriesof IARC Regional Hubs for CancerRegistration in Africa, Asia, and Latin America have been established.A tailored set of recommended localactivities involving training, technical guidance, research capacitybuilding, and advocacy are providedto increase the data quality, coverage, and utility of PBCRs in servingcancer control purposes.Executive summary. Planning and developing population-based cancer registration in low- and middle-income settingsix

AbbreviationsASRage-standardized rate (World Standard) per 100 000CDCCenters for Disease Control and PreventionCI5Cancer Incidence in Five ContinentsCTcomputed tomographyDCOdeath certificate onlyDCO%percentage of cases for which the only information came from a death certificateENCREuropean Network of Cancer RegistriesGICRGlobal Initiative for Cancer Registry DevelopmentHBCRshospital-based cancer registriesHDIHuman Development IndexHPVhuman papillomavirusIACRInternational Association of Cancer RegistriesIARCInternational Agency for Research on CancerIARCcrgToolsIARC–IACR Cancer Registry ToolsICD-10International Statistical Classification of Diseases and Related Health Problems, 10th RevisionICD-OInternational Classification of Diseases for OncologyICD-O-3International Classification of Diseases for Oncology, 3rd EditionLMICslow- and middle-income countriesM:Imortality-to-incidence ratioM:I%percentage mortality-to-incidence ratioMRImagnetic resonance imagingMV%percentage of cases with a morphologically verified diagnosisNCDsnoncommunicable diseasesNCRPNational Cancer Registry ProgramPBCRspopulation-based cancer registriesSEERSurveillance, Epidemiology, and End ResultsTNMtumour–node–metastasisUICCUnion for International Cancer ControlWHOWorld Health OrganizationxAbbreviations

CHAPTER 1chapter 1.IntroductionChanging fertility rates, increasing longevity, and changing lifestyleshave led to an increasing burden fromnoncommunicable diseases (NCDs)worldwide: of the estimated 55 million deaths occurring globally in 2011,almost two thirds were deaths fromNCDs (WHO, 2011). The morbidity and mortality from NCDs are setto further increase over the next fewdecades, and for cancer, more than20 million new cases are anticipatedworldwide in 2025, with four fifths ofthe burden falling on low- and middle-income countries (LMICs) (Bray,2014). According to World Health Organization (WHO) estimates in 2011,cancer is now the leading cause ofdeath worldwide (Fig. 1.1).In recognition of the rising burden, WHO Member States during the65th World Health Assembly agreedto adopt a global target of a 25% reduction in premature mortality fromFig. 1.1. The 10 leading causes of death worldwide in 2011, for all ages and bothsexes. COPD, chronic obstructive pulmonary disease. Source: Data compiledfrom the Global Health Observatory Data Repository (http://apps.who.int/gho/data/).Chapter 1. Introduction1

cancer and the other major NCDs(cardiovascular diseases, respiratorydiseases, and diabetes) by 2025. Anaction plan and its monitoring framework have subsequently been adopted to achieve the target (WHO, 2013).NCD surveillance is critical toproviding the information needed forpolicy and programme development,and to support the monitoring andevaluation of the progress made inimplementing NCD policies and programmes. Cancer registries are theonly disease-specific registries thatare in use for NCDs and are therefore of pivotal importance not only inassessing the cancer burden but alsoin measuring the impact of interventions in cancer prevention and control.Population-based cancer registries(PBCRs) are thus a unique sourceof information for research and public health programme monitoring. Inimplementing the NCD action plan,WHO is mandated to report back onprogress towards achieving the nineglobal targets in 2015, 2020, and2025. The monitoring of indicatorsin the WHO Medium-Term StrategicPlan is linked directly to the indicatorsand targets agreed by Member Statesat the 66th World Health 32/B132 27-en.pdf).To provide information on progress in the implementation of the action plan, Member States agreed tothe collection of 25 indicators, including “cancer incidence”. More specifically, the request is for governmentsto collect data on “cancer incidence,by type of cancer, per 100 000 population”, and thus commit to developingand sustaining PBCRs. The PBCRis unique in that it systematically collects and classifies information on allreportable cancers occurring in a geographically defined population frommultiple sources, including hospitals,diagnostic laboratories, and vital statistics departments. As well as collating the data, PBCRs are responsiblefor analysing and reporting. The routine calculation of rates “per 100 000”by PBCRs provides information onhow the cancer patterns are affectingtheir communities and how the trendsin different cancers are evolving.PBCRs provide the solid basis for theplanning, establishment, monitoring,and evaluation of cancer control programmes and the dimension of cancercare services required.This guidance document consistsof six chapters that provide technicaladvice to planners and health specialists in LMICs wishing to implement anddevelop PBCRs as information systems that inform cancer control policy.This first chapter has placed the needfor cancer registration in the contextof the rapidly increasing burden fromthe disease seen worldwide. Chapter2 describes the characteristics of thedifferent types of cancer registry andthe unique functions of PBCRs andtheir present status worldwide. Chapters 3 and 4 outline the critical stepsin planning and developing a PBCRin lower-resource settings, includingdiscussion of the key sources of information required and the minimal standard set of data items that the PBCRshould collect. Aspects in the set-upthat will help ensure the sustainabilityof the registry are emphasized, including comments on infrastructure andresource requirements as well as thecommitment of stakeholders. Chapter 5 describes the main techniquesto evaluate and further enhance thedata quality at the PBCR. Chapter 6provides some advice on reportingthe results to the community at largein support of cancer control and thuspromoting the increasing utility of theregistry.Key points Along with an increasing NCD burden, more than 20 million new cases of cancer are predicted worldwide in2025, with four fifths of the burden falling on LMICs. As a response, WHO Member States have agreed to adopt a global NCD target of a 25% reduction in prematuremortality from the four major NCDs by 2025 and to collect data on cancer incidence by type to provideinformation on progress. PBCRs are critical for collecting and collating such incidence data so as to assess how cancer patterns areaffecting their populations and how trends in different cancers are evolving. They provide the solid basis for theestablishment, monitoring, and evaluation of cancer control programmes.2

The role and statusof population-basedcancer registrationPopulation-based cancer registration represents the gold standard forthe provision of information on cancer incidence in a defined population;PBCRs can serve to identify possiblecauses of cancer in the communityand to assess the impact of cancercontrol activities. A functioning healthcare system is, however, of critical importance to achieve full case ascertainment and an unbiased picture ofthe true cancer burden.Fig. 2.1 compares present levelsof the national Human DevelopmentIndex (HDI) (Fig. 2.1A) versus available sources of cancer incidence(Fig. 2.1B) and mortality (Fig. 2.1C)data. Cancer incidence and mortality data are more commonly available in countries that have attainedhigh or very high levels of HDI; suchcountries have a longer history of reasonably complete national mortalitystatistics, and many have developedeither a national PBCR or one or moreregional PBCRs over the past decades, notably during the 1970s and1980s. In such settings, the activitiesof PBCRs have developed far beyondthe basic role of estimating rates andcomparing cancer profiles in differentpopulations (Parkin, 2006). Registriesexpand their range of activities asthey develop, undertaking studies ofcancer causes and prevention, andproviding the information required inplanning and evaluating cancer control programmes (see Box 2.1).The situation is different for countries presently categorized as havinglow or medium HDI. In many of theseareas of the world, most notably insub-Saharan Africa and South Asia,both vital registration and PBCR systems of reasonable quality have beenslower to emerge.1. What is the status ofpopulation-based cancerregistration worldwide?The concept of population-basedcancer registration has been in existence for well over half a century,with the first PBCR founded in the1930s. Currently, there are more than700 PBCRs worldwide, although theirpace of development has been muchslower in LMICs than in high-incomecountries. This reflects a shortageof human and financial resourcesin LMICs, rather than a lack ofawareness of need. The CancerIncidence in Five Continents (CI5)series (http://ci5.iarc.fr) published byIARC and the International Association of Cancer Registries (IACR) isregarded as the definitive source ofhigh-quality cancer incidence data,and in Volume X published incidencedata for the period circa 2003–2007.Chapter 2. The role and status of population-based cancer registration3CHAPTER 2chapter 2.

Fig. 2.1. Global maps depicting (A) the development level of individual countries, according to the four-level Human Development Index (HDI), based onquartiles, for 2012; (B) status of population-based cancer registries (PBCRs),as of mid-2013; (C) status of vital registration systems, as of mid-2013. Sourcefor A, B: Data compiled from the United Nations Development Programme.ALow HDIMedium HDIHigh HDIVery high HDIBI High-quality PBCR (national)II High-quality PBCR (regional)III PBCR (national or regional)IV Registration activityV No data/status unknownC1 High-quality complete vital registration2 Medium-quality complete vital registration3 Low-quality complete vital registration4 Incomplete or sample vital registration5 Other sources (cancer registries verbal autopsy surveys, etc.)6 No data4Although there is a substantial disparity between high-HDI countriesand low- or middle-HDI countries incoverage in CI5 (e.g. almost completecoverage in North America compared with 10% in South America,Asia, and Africa), the circumstancesare less bleak when it is consideredwhether cancer information is available and can be built upon in a givencountry in these regions.A series of IARC Regional Hubsfor Cancer Registration in Africa,Asia, and Latin America have beenestablished and will be the first pointof call for countries within the respective regions. The Hubs in liaison withIARC develop specific tools in supportof registries to: assess cancer registry quality, publication, and presentation of data assess capacity for registry development and evaluate the quality ofexisting registries m onitor overall progress in expandingcoverage of cancer registration coordinate the development, follow-up, and evaluation of formalagreements between individual cancer registries and IARC, coveringspecific activities consistent with theneeds and recommendations and atime-limited plan coordinate research projects, including the development of monographsin collaboration with IARC, including continental reports based on allavailable registry data in the Hubregion.Currently, the registration status ofthe 138 countries within the six Hubscan be placed into one of five categories, as indicated in Fig. 2.1B:Grade I. High-quality PBCRs (included in CI5 Volume X) and nationally representative (registries withcoverage of 50% of the country’spopulation)Grade II. High-quality PBCRs(included in CI5 Volume X) and regionally representative ( 50% coverage)Grade III. Nat

iarc technical publications planning and developing population-based cancer registration in low- and middle-income settings freddie bray, ariana znaor, patricia cueva, anne korir, rajaraman swaminathan, andreas ullrich, susan a. wang, and donald maxwell

Related Documents:

TSCA 12b U.S. State Regulations Chemical Name Regulation CAS # % Agents Classified by IARC Monographs Not applicable IARC Group 1 Not applicable IARC Group 2A Not applicable IARC Group 2B SAFETY DATA SHEET. Chemical Name Regulation CAS # % None. Californi

IARC Library Cataloguing in Publication Data Air pollution and cancer / editors, K. Straif, A. Cohen, J. Samet (IARC Scientific Publications; 161) 1. Air Pollutants 2. Environmental Pollutants 3. Air Pollution, Indoor 4. Carcinogens, Envir

The International Agency for Research on Cancer (IARC) has a mandate . IARC Diesel Exhaust & Lung Cancer AN ANALYSIS. IARC Diesel Exhaust and Lung Cancer An Analysis A publication of the . Monographs are an exercise in evaluation of cancer hazards, and then using the word ‘risk’ in the title.

Exhaust Diesel, gasoline 14 . IARC Evaluation Priorities 2010 . Report of the Advisory Group to Recommend Priorities for IARC Monographs during 2010–2014. IARC, Internal Report 08/001. Lyon, France, 2008. Epidemiologic Studies the Causes of Cancer

Diesel and gasoline engine exhausts and some nitroarenes. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 46. Lyon: IARC, 1989. 2. Benbrahim-Tallaa L, Baan RA, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Guha N, Loomis D, Straif K, on behalf of the International Agency for Research on Cancer Monograph .

The International Agency for Research on Cancer (IARC) in 2012 upgraded its cancer hazard classification of diesel engine exhaust exposure to Category 1 of “carcinogenic to humans” based on what IARC asserted was adequate or sufficient epidemiological evidence. 1

IARC. 1989. 1,6-Dinitropyrene. In Diesel and Gasoline Engine Exhausts and Some Nitroarenes. IARC Monographs Evaluation of Carcinogenic Risks of Chemicals to Humans, vol. 46. Lyon, France: International Agency for Research on Cancer. pp. 215-230. IPCS. 2003. Environmental Health Criteria No. 229. Selected Nitro- and Nitro-oxy-polycyclic Aromatic

achieving this standard in all units within one to two years may not be possible. Therefore, the qualifications have been designed as Level 1/Level 2 qualifications with grades available at Level 2 and at Level 1 Pass. Improved specification and support In our consultation, we also asked about what kind of guidance you, as teachers and tutors, need. As a result, we have streamlined the .